eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW was delisted on the 2nd of July, 2024.
11 hedge funds and large institutions have $280K invested in eFFECTOR Therapeutics, Inc. Warrant in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
8% less funds holding
Funds holding: 12 → 11 (-1)
14% less capital invested
Capital invested by funds: $326K → $280K (-$46.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOA
Sea Otter Advisors
Miami,
Florida
|
+$3.98K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
-$1.64K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$179 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Aristeia Capital
Greenwich,
Connecticut
| $153K | – | – | – |
|
2
Goldman Sachs
New York
| $47.3K | – | – | – |
|
|
WA
3
Whitebox Advisors
Minneapolis,
Minnesota
| $38.5K | – | – | – |
|
|
MI
4
MMCAP International
Grand Cayman,
Cayman Islands
| $18.9K | – | – | – |
|
|
PA
5
Parallel Advisors
San Francisco,
California
| $4.81K | – | – | – |
|
|
TCM
6
Tenor Capital Management
New York
| $4.31K | – | – | – |
|
|
ICM
7
III Capital Management
Boca Raton,
Florida
| $4.15K | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| $3.58K | +$1.07K | +6,710 | +32% |
|
|
SOA
9
Sea Otter Advisors
Miami,
Florida
| $3.23K | +$3.98K | +25,000 | New |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $1.86K | -$179 | -1,127 | -7% |
|
|
JFG
11
Jefferies Financial Group
New York
| – | -$1.64K | -10,000 | Closed |
|
EFTRW Hedge Fund Activity: Q1 2023 in Review
11 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q1 2023, worth a combined $280K — down 14% from $326K a quarter earlier.
Fund positioning in EFTRW was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Sea Otter Advisors, opening a new position worth an estimated $3.98K. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $1.64K sold.
- 11 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q1 2023, down from 12 in Q4 2022.
- Funds reported $280K of eFFECTOR Therapeutics, Inc. Warrant stock for Q1 2023, down 14% quarter-over-quarter.
- 1 fund opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q1 2023 was Sea Otter Advisors, an estimated $3.98K added.
- The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q1 2023 was Jefferies Financial Group, an estimated $1.64K sold.
Based on aggregated 13F filings for Q1 2023.